Research Paper Volume 15, Issue 11 pp 5032—5051
CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis
Figure 6. The positive association between CLDN5 expression and stromal score (A, B) and immune score (C, D) in top 8 tumors.